CLEOPATTRA: Effects of NNC6019-0001 versus placebo on cardiovascular outcomes in participants with transthyretin amyloid cardiomyopathy (ATTR-CM) Acronym:
Clinical Trial Grant
Awarded By
Novo Nordisk A/S
Start Date
May 6, 2026
End Date
April 30, 2031
Awarded By
Novo Nordisk A/S
Start Date
May 6, 2026
End Date
April 30, 2031